Literature DB >> 18457922

Differential effect of type I and type II interferons on neopterin production and amino acid metabolism in human astrocyte-derived cells.

Oscar D Cano1, Gabriele Neurauter, Dietmar Fuchs, Gene M Shearer, Adriano Boasso.   

Abstract

Intrathecal production of neopterin, a pteridine produced by interferon (IFN)-gamma-stimulated monocyte-derived macrophages, is associated with neurological disorders and infections. We investigated whether IFN-alpha/beta, IFN-gamma, or human immunodeficiency virus (HIV) induce neopterin production by human astroglioma cells. IFN-alpha/beta and IFN-gamma, but not HIV, induced neopterin. Interestingly, IFN-gamma, but not IFN-alpha/beta, increased expression and activity of the tryptophan-catabolizing enzyme indoleamine (2,3)-dioxygenase. In contrast, IFN-alpha/beta, but not IFN-gamma, reduced the uptake of three aromatic amino acids in U87MG and U138 astroglioma cells. Thus type I and type II IFN stimulate astrocyte-derived cells to produce neopterin and exert differential effects on amino acid metabolism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18457922      PMCID: PMC6924613          DOI: 10.1016/j.neulet.2008.04.046

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  24 in total

Review 1.  Sites, mechanism of action and lack of reversibility of primate lentivirus inactivation by preferential covalent modification of virion internal proteins.

Authors:  Elena Chertova; Bruce J Crise; David R Morcock; Julian W Bess; Louis E Henderson; Jeffrey D Lifson
Journal:  Curr Mol Med       Date:  2003-05       Impact factor: 2.222

2.  Simultaneous measurement of serum tryptophan and kynurenine by HPLC.

Authors:  B Widner; E R Werner; H Schennach; H Wachter; D Fuchs
Journal:  Clin Chem       Date:  1997-12       Impact factor: 8.327

3.  Inflammation marker 7,8-dihydroneopterin induces apoptosis of neurons and glial cells: a potential contribution to neurodegenerative processes.

Authors:  C Speth; G Stöckl; D Fuchs; B Wirleitner; B Widner; R Würzner; I Mohsenipour; C Lass-Flörl; M P Dierich
Journal:  Immunobiology       Date:  2000-11       Impact factor: 3.144

Review 4.  Indoleamine-2, 3-dioxygenase and other interferon-gamma-mediated pathways in patients with human immunodeficiency virus infection.

Authors:  Katharina Schroecksnadel; R Zangerle; R Bellmann-Weiler; K Garimorth; G Weiss; Dietmer Fuchs
Journal:  Curr Drug Metab       Date:  2007-04       Impact factor: 3.731

5.  Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions.

Authors:  Anne-Sophie Beignon; Kelli McKenna; Mojca Skoberne; Olivier Manches; Ida DaSilva; Daniel G Kavanagh; Marie Larsson; Robert J Gorelick; Jeffrey D Lifson; Nina Bhardwaj
Journal:  J Clin Invest       Date:  2005-10-13       Impact factor: 14.808

6.  Cerebrospinal fluid neopterin concentrations in central nervous system infection.

Authors:  L Hagberg; L Dotevall; G Norkrans; M Larsson; H Wachter; D Fuchs
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

Review 7.  Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects.

Authors:  B Wirleitner; G Neurauter; K Schröcksnadel; B Frick; D Fuchs
Journal:  Curr Med Chem       Date:  2003-08       Impact factor: 4.530

8.  Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections.

Authors:  O Adams; K Besken; C Oberdörfer; C R MacKenzie; O Takikawa; W Däubener
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 9.  The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases.

Authors:  D Fuchs; G Weiss; G Reibnegger; H Wachter
Journal:  Crit Rev Clin Lab Sci       Date:  1992       Impact factor: 6.250

10.  Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.

Authors:  C Huber; J R Batchelor; D Fuchs; A Hausen; A Lang; D Niederwieser; G Reibnegger; P Swetly; J Troppmair; H Wachter
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

View more
  7 in total

1.  Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation.

Authors:  Viktor Dahl; Julia Peterson; Dietmar Fuchs; Magnus Gisslen; Sarah Palmer; Richard W Price
Journal:  AIDS       Date:  2014-09-24       Impact factor: 4.177

2.  Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.

Authors:  Lars Hagberg; Paola Cinque; Magnus Gisslen; Bruce J Brew; Serena Spudich; Arabella Bestetti; Richard W Price; Dietmar Fuchs
Journal:  AIDS Res Ther       Date:  2010-06-03       Impact factor: 2.250

3.  Possible changes of New-Generation inflammation markers with occupational lead exposure.

Authors:  Hande Sipahi; Gozde Girgin; Saziye Sezin Palabiyik; Engin Tutkun; Omer Hinc Yilmaz; Terken Baydar
Journal:  J Occup Health       Date:  2017-06-07       Impact factor: 2.708

4.  The diagnostic role and dynamic changes in cerebrospinal fluid neopterin during treatment of patients with primary central nervous system lymphoma.

Authors:  Mingying Geng; He Xiao; Jiaqi Liu; Yang Song; Ping Fu; Xing Cheng; Jinwei Zhang; Ge Wang
Journal:  Cancer Med       Date:  2018-07-07       Impact factor: 4.452

5.  Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy.

Authors:  Aylin Yilmaz; Constantin T Yiannoutsos; Dietmar Fuchs; Richard W Price; Kathryn Crozier; Lars Hagberg; Serena Spudich; Magnus Gisslén
Journal:  J Neuroinflammation       Date:  2013-05-10       Impact factor: 8.322

Review 6.  Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection.

Authors:  Richard W Price; Julia Peterson; Dietmar Fuchs; Thomas E Angel; Henrik Zetterberg; Lars Hagberg; Serena Spudich; Richard D Smith; Jon M Jacobs; Joseph N Brown; Magnus Gisslen
Journal:  J Neuroimmune Pharmacol       Date:  2013-08-13       Impact factor: 4.147

Review 7.  Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders.

Authors:  Aylin Yilmaz; Dietmar Fuchs; Richard W Price; Serena Spudich; Kaj Blennow; Henrik Zetterberg; Magnus Gisslén
Journal:  Curr HIV/AIDS Rep       Date:  2019-02       Impact factor: 5.071

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.